Pascal Deschatelets - 08 Jul 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Reporting relationship
Chief Scientific Officer
Issuer ticker
APLS
Reported as of
08 Jul 2022
Net transaction value
-$526,005
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Jul 2022, 16:04:36 UTC
Prior SEC filing
22 Jun 2022
Next SEC filing
09 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Watson, attorney-in-fact for Pascal Deschatelets

Key filing fact

Pascal Deschatelets filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 12 Jul 2022.

Key facts

  • This page summarizes Pascal Deschatelets's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 12 Jul 2022, 16:04.

Change

  • Previous filing in this sequence was filed on 22 Jun 2022.
  • Current net transaction value: -$526,005.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APLS transaction

Common Stock

Options Exercise

Transaction value
$32,040
Shares
+12,000
Change %
+1.3%
Price
$2.67*
Shares after
943,280
Date
08 Jul 2022
Ownership
Direct
Footnotes
F1
APLS transaction

Common Stock

Options Exercise

Transaction value
$17,355
Shares
+6,500
Change %
+0.69%
Price
$2.67*
Shares after
949,780
Date
08 Jul 2022
Ownership
Direct
Footnotes
F2
APLS transaction

Common Stock

Sale

Transaction value
$575,400
Shares
-12,000
Change %
-1.3%
Price
$47.95
Shares after
937,780
Date
08 Jul 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APLS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-12,000
Change %
-3.8%
Price
$0.000000
Shares after
301,494
Date
08 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,000
Exercise price
$2.67
Footnotes
F1, F3
APLS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-6,500
Change %
-2.2%
Price
$0.000000
Shares after
294,994
Date
08 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,500
Exercise price
$2.67
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This is a scheduled exercise and sale from a 10B5-1 trading plan.

Footnote F2

This is a scheduled exercise from 10B5-1 trading plan.

Footnote F3

This stock option was granted on 12/5/2013 and is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .